Company news
Precipio, Inc. news in 2022
Precipio, Inc.'s news releases, calls and decks from 2022, newest first.
Precipio Signs Additional Major HemeScreen™ Customer
December 5, 2022
Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference
November 6, 2022
Precipio Announces Third Quarter Shareholder Update Call
November 1, 2022
Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™
September 14, 2022
Sharon Robins Joins Precipio’s Products Division as Senior Director of Laboratory & Hospital Sales
August 23, 2022
Precipio Launches New 1-Step Technology for all HemeScreen Assays
August 15, 2022
Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development
August 9, 2022
Precipio Announces Second Quarter Shareholder Update Call
August 7, 2022
Precipio to distribute HemeScreen® through Fisher Healthcare channel
July 19, 2022
Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote
June 13, 2022
Keith Meadors Joins Precipio to Lead its Products Division
June 12, 2022
Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe
May 23, 2022
Precipio Signs First IV-Cell Customer Agreement
May 9, 2022
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference
April 25, 2022
Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call
March 21, 2022
Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO
March 20, 2022
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022
February 23, 2022
Calls in 2022
Decks in 2022
- Investor Presentation (June 2022)
Investor deck · 12 slides · Jun 13, 2022